Odyssey Health (ODYY) Receivables - Net (2016 - 2024)
Odyssey Health (ODYY) posted quarterly Receivables - Net of $22625.0 for Q3 2024, up 2050.67% quarter-over-quarter from $1052.0 in Q4 2017.
Odyssey Health (ODYY) Receivables - Net (2016 - 2024) Analysis & Trends
Odyssey Health's Receivables - Net history runs 3 years deep, the most recent figure standing at $22625.0 for Q3 2024.
- In Q3 2024, Receivables - Net changed N/A year-over-year to $22625.0; the TTM figure through Jul 2024 stood at $22625.0 (changed N/A YoY), while the FY2024 annual figure was $22625.0, changed N/A from the prior year.
- Receivables - Net for Q3 2024 stood at $22625.0, up from $1052.0 in the prior quarter.
- The five-year high for Receivables - Net was $22625.0 in Q3 2024, with the low at $22625.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn |
| 10 | Odyssey Health | 1.01 Mn | 711,880.61 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2024 | 22,625.00 |
| Jul 31, 2024 | 22,625.00 |
| Oct 31, 2017 | 1,052.00 |
| Oct 31, 2017 | 1,052.00 |
| Jul 31, 2017 | 1,052.00 |
| Jul 31, 2017 | 1,052.00 |
| Apr 30, 2017 | 1,052.00 |
| Apr 30, 2017 | 1,052.00 |
| Jan 31, 2017 | 1,052.00 |
| Jan 31, 2017 | 1,052.00 |
| Oct 31, 2016 | 11,052.00 |
| Oct 31, 2016 | 11,052.00 |
| Jul 31, 2016 | 18,052.00 |
| Jul 31, 2016 | 18,052.00 |
| Apr 30, 2016 | 22,500.00 |
| Apr 30, 2016 | 22,500.00 |